Free Trial
NASDAQ:NRXS

NeurAxis (NRXS) Stock Price, News & Analysis

NeurAxis logo
$2.41 -0.01 (-0.41%)
Closing price 04:00 PM Eastern
Extended Trading
$2.41 0.00 (0.00%)
As of 06:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About NeurAxis Stock (NASDAQ:NRXS)

Key Stats

Today's Range
$2.23
$2.45
50-Day Range
$2.00
$3.99
52-Week Range
$1.33
$6.20
Volume
147,272 shs
Average Volume
422,451 shs
Market Capitalization
$17.39 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00
Consensus Rating
Buy

Company Overview

NeurAxis Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
70th Percentile Overall Score

NRXS MarketRank™: 

NeurAxis scored higher than 70% of companies evaluated by MarketBeat, and ranked 286th out of 925 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    NeurAxis has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    NeurAxis has only been the subject of 1 research reports in the past 90 days.

  • Read more about NeurAxis' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of NeurAxis is -1.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of NeurAxis is -1.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    0.52% of the float of NeurAxis has been sold short.
  • Short Interest Ratio / Days to Cover

    NeurAxis has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in NeurAxis has recently decreased by 62.02%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    NeurAxis does not currently pay a dividend.

  • Dividend Growth

    NeurAxis does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.52% of the float of NeurAxis has been sold short.
  • Short Interest Ratio / Days to Cover

    NeurAxis has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in NeurAxis has recently decreased by 62.02%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    NeurAxis has a news sentiment score of 0.68. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.58 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for NeurAxis this week, compared to 1 article on an average week.
  • MarketBeat Follows

    Only 1 people have added NeurAxis to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, NeurAxis insiders have sold 122.31% more of their company's stock than they have bought. Specifically, they have bought $831,253.00 in company stock and sold $1,847,986.00 in company stock.

  • Percentage Held by Insiders

    26.40% of the stock of NeurAxis is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 11.77% of the stock of NeurAxis is held by institutions.

  • Read more about NeurAxis' insider trading history.
Receive NRXS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NeurAxis and its competitors with MarketBeat's FREE daily newsletter.

NRXS Stock News Headlines

NeurAxis (NASDAQ:NRXS) Trading Down 2% - What's Next?
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
See More Headlines

NRXS Stock Analysis - Frequently Asked Questions

NeurAxis' stock was trading at $2.35 at the start of the year. Since then, NRXS stock has increased by 2.6% and is now trading at $2.41.

NeurAxis, Inc. (NASDAQ:NRXS) issued its quarterly earnings results on Tuesday, November, 12th. The company reported ($0.25) earnings per share (EPS) for the quarter. The firm earned $0.67 million during the quarter.

NeurAxis (NRXS) raised $7 million in an initial public offering (IPO) on Wednesday, August 9th 2023. The company issued 1,098,667 shares at $6.00 per share.

Shares of NRXS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that NeurAxis investors own include AutoZone (AZO), Intel (INTC), Meta Platforms (META), Outdoor (POWW), SPDR S&P 500 ETF Trust (SPY), TJX Companies (TJX) and ETRACS Crude Oil Shares Covered Call ETN (USOI).

Company Calendar

Last Earnings
11/12/2024
Today
7/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Electromedical equipment
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:NRXS
CIK
1933567
Fax
N/A
Employees
19
Year Founded
N/A

Price Target and Rating

High Price Target
$7.00
Low Price Target
$7.00
Potential Upside/Downside
+190.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.19)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$14.63 million
Net Margins
-492.76%
Pretax Margin
-341.35%
Return on Equity
N/A
Return on Assets
-641.25%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.24
Quick Ratio
0.23

Sales & Book Value

Annual Sales
$2.93 million
Price / Sales
5.93
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.27) per share
Price / Book
-8.93

Miscellaneous

Outstanding Shares
7,216,000
Free Float
6,085,000
Market Cap
$17.39 million
Optionable
Not Optionable
Beta
3.09
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:NRXS) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners